Abstract:Objective To analyze the causative drugs of drug eruptions, basing on the data of a hos-pitalized population from Department of Dermatology, Huashan Hospital during past 10 years. Methods Clinical records of patients with diagnosis of drug eruption were collected and analyze retrospectively, who were admitted into inpatients ward of Department of Dermatology, Huashan Hospital since January 2007 to December 2016. Results A total of 1883 [ male: 652, ( 34. 63%) , female 1231 ( 65. 37%) ] pa-tients were enroll in this study. The most common types of drug eruptions were urticaria (27. 19%), mac-ulopapular exanthema (MPE, 24. 69%), erythema multiforme (EM) -like eruptions (22. 04%), fol-lowed by three kinds of severe types including Stevens-Johnson syndrome ( SJS, 12. 16%) , drug reaction with eosinophils and systemic syndrome ( DRESS, 4. 30%) and toxic epidermal necrolysis ( TEN, 4. 25%) . 53. 43% patients were diagnosed as multiple drugs induced drug eruptions and 45. 83% as single drug induced drug eruptions. The top five most common causative drugs for single drug induced drug eruptions were antibiotics ( 28. 85%) , Traditional Chinese medicine ( TCM, 15. 99%) , antiepileptic agents (13. 56%), anti-hyperuricemia agents (12. 86%) and antipyretic/analgesic agents (9. 15%). The top five most common causative drugs for single drug induced severe drug eruptions were antiepileptic agents ( 36. 15%) , anti-hyperuricemia agents ( 31. 46%) , antibiotics ( 7. 98%) , TCM ( 5. 63%) and antipyretic/analgesic agents ( 5. 63%) . There was one kind of antibiotics and at least two kinds of antibi-otics in suspected causative drugs in 36. 18% and 31. 41% patients with multiple drugs induced drug eruptions respectively. 37. 97% patients with multiple drugs induced drug eruptions were prescribed at least one kind of TCM within the latency period. Conclusion The top two kinds of most common causa-tive drugs for drug eruptions were antibiotics and TCM. The number of TCM induced drug eruptions in-creased remarkably during the recent years. TCM induced drug eruptions should be vigilant.

Application of enzyme-linked immunospot assay in the identification of culprit drugs in severe drug eruptions

Association Between Serum Ferritin and the Severity of Drug Eruptions

In‐vivo and ex‐vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions

Drug-induced Erythroderma in Patients with Acquired Immunodeficiency Syndrome.

The clinical analysis of 73 cases with severe drug eruption

Clinical Application of T-SPOT.TB in Diagnosis of HIV/AIDS and TB Patients

On-line screening and verification of haptens in Xiangdan injection combining chemical analysis with activity detection

A New Method of Tuberculosis Infection Diagnosis—Enzyme-Linked Immunospot Assay

Clinical Analysis of 368 Patients with Drug Eruptions

Role of in vivo and in vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug

Analysis on Causative Drugs of 1883 Drug Eruptions in a Hospitalized Population

An Modified Enzyme-linked Immunospot Method and Its Application to the Detection of IgG Secretion

An epidermal equivalent assay for identification and ranking potency of contact sensitizers

Analysis of 112 Cases of Severe Drug Eruption

Intravenous immunoglobulin treatment of severe drug eruptions compticated with severe skin infections

[Clinical Characteristics and Prognosis for 126 Patients with Severe Drug Eruption].

Study on the Change of the Function of Coagulation System and Platelet System in Patients with Drug Eruption

[Application of Serum Total IgE, Tryptase and Chymase in the Identification of Death Caused by Drug Anaphylactic Shock].

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions

Retrospective Study with 44 Cases with Severe Drug Eruptions

Clinical analysis on 33 patients with severe drug eruption caused by antiepileptic drugs